243 related articles for article (PubMed ID: 2426419)
1. High-dose versus low-dose vinblastine in cisplatin-vinblastine-bleomycin combination chemotherapy of non-seminomatous testicular cancer: a randomized study of the EORTC Genitourinary Tract Cancer Cooperative Group.
Stoter G; Sleyfer DT; ten Bokkel Huinink WW; Kaye SB; Jones WG; van Oosterom AT; Vendrik CP; Spaander P; de Pauw M; Sylvester R
J Clin Oncol; 1986 Aug; 4(8):1199-206. PubMed ID: 2426419
[TBL] [Abstract][Full Text] [Related]
2. Prognostic factors for favorable outcome in disseminated germ cell tumors.
Birch R; Williams S; Cone A; Einhorn L; Roark P; Turner S; Greco FA
J Clin Oncol; 1986 Mar; 4(3):400-7. PubMed ID: 2419524
[TBL] [Abstract][Full Text] [Related]
3. A randomized trial of cisplatin, vinblastine, and bleomycin versus vinblastine, cisplatin, and etoposide in the treatment of advanced germ cell tumors of the testis: a Southwest Oncology Group study.
Wozniak AJ; Samson MK; Shah NT; Crawford ED; Ford CD; Altman SJ; Stephens RL; Natale RB; Bouroncle BA; Blumenstein BA
J Clin Oncol; 1991 Jan; 9(1):70-6. PubMed ID: 1702148
[TBL] [Abstract][Full Text] [Related]
4. Early resection of residual tumor during cisplatin, vinblastine, bleomycin combination chemotherapy in stage III and bulky stage II nonseminomatous testicular cancer.
Pizzocaro G; Salvioni R; Pasi M; Zanoni F; Milani A; Pilotti S; Monfardini S
Cancer; 1985 Jul; 56(2):249-55. PubMed ID: 2408728
[TBL] [Abstract][Full Text] [Related]
5. Successful treatment of good-risk disseminated testicular cancer with cisplatin, bleomycin, and reduced-dose vinblastine.
Pizzocardo G; Salvioni R; Zanoni F; Milani A; Piva L
Cancer; 1986 Jun; 57(11):2114-8. PubMed ID: 2421865
[TBL] [Abstract][Full Text] [Related]
6. A 20% dose reduction of the original CISCA/VB regimen allows better tolerance and similar survival rate in disseminated testicular non-seminomatous germ-cell tumors: final results of a phase III randomized trial.
Fizazi K; Do KA; Wang X; Finn L; Logothetis CJ; Amato RJ
Ann Oncol; 2002 Jan; 13(1):125-34. PubMed ID: 11863094
[TBL] [Abstract][Full Text] [Related]
7. Cisplatin combination chemotherapy for advanced germ-cell testicular tumours.
Taylor RE; Duncan W; Davey P; Munro AJ; Cornbleet MA
Br J Urol; 1985 Oct; 57(5):567-73. PubMed ID: 2415203
[TBL] [Abstract][Full Text] [Related]
8. Five-year survival of patients with disseminated nonseminomatous testicular cancer treated with cisplatin, vinblastine, and bleomycin.
Stoter G; Vendrik CP; Struyvenberg A; Sleyfer DT; Vriesendorp R; Schraffordt Koops H; van Oosterom AT; ten Bokkel Huinink WW; Pinedo HM
Cancer; 1984 Oct; 54(8):1521-4. PubMed ID: 6206937
[TBL] [Abstract][Full Text] [Related]
9. Improving the outcome of salvage treatment for non-seminomatous germ cell tumours (NSGCT).
de Bono JS; Paul J; Simpson A; Anthoney A; Kirk D; Underwood M; Graham J; Kaye SB
Br J Cancer; 2000 Aug; 83(4):426-30. PubMed ID: 10945485
[TBL] [Abstract][Full Text] [Related]
10. Elevated serum tumor markers in patients with testicular cancer after induction chemotherapy due to a reservoir of markers in cystic differentiated mature teratoma.
van der Gaast A; Hoekstra JW; Croles JJ; Splinter TA
J Urol; 1991 Apr; 145(4):829-31. PubMed ID: 1706441
[TBL] [Abstract][Full Text] [Related]
11. Treatment of testicular cancer: a new and improved model.
Einhorn LH
J Clin Oncol; 1990 Nov; 8(11):1777-81. PubMed ID: 1700077
[TBL] [Abstract][Full Text] [Related]
12. Second malignancy after cisplatin, vinblastine, and bleomycin (PVB) chemotherapy: a case report.
Mead GM; Green JA; Macbeth FR; Williams CJ; Whitehouse JM; Buchanan R
Cancer Treat Rep; 1983 Apr; 67(4):410. PubMed ID: 6189603
[No Abstract] [Full Text] [Related]
13. [Case report of a non-seminomatous testicular neoplasm indicating marked efficacy of a combination chemotherapy of VBL, ACTD, BLM, CDDP and EX (VAB-4 combination therapy)].
Hayashi M; Ebihara K; Urano E
Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2775-7. PubMed ID: 6210063
[TBL] [Abstract][Full Text] [Related]
14. [Tumor markers as a prognostic factor of the response to treatment in cancer of the testicle].
Germa Lluch JR; Bastus Piulats R
Actas Urol Esp; 1987; 11(3):293-8. PubMed ID: 2444075
[No Abstract] [Full Text] [Related]
15. A randomized trial of etoposide + cisplatin versus vinblastine + bleomycin + cisplatin + cyclophosphamide + dactinomycin in patients with good-prognosis germ cell tumors.
Bosl GJ; Geller NL; Bajorin D; Leitner SP; Yagoda A; Golbey RB; Scher H; Vogelzang NJ; Auman J; Carey R
J Clin Oncol; 1988 Aug; 6(8):1231-8. PubMed ID: 2457657
[TBL] [Abstract][Full Text] [Related]
16. Non-seminomatous testicular germ cell tumours. Preliminary analysis of ongoing trials in the DATECA Study.
Rørth M; von der Maase H; Sandberg Nielsen E; Schultz HP; Svennekjaer IL
Acta Radiol Oncol; 1984; 23(4):295-304. PubMed ID: 6208750
[TBL] [Abstract][Full Text] [Related]
17. Dose-response and dose-survival advantage for high versus low-dose cisplatin combined with vinblastine and bleomycin in disseminated testicular cancer. A Southwest Oncology Group study.
Samson MK; Rivkin SE; Jones SE; Costanzi JJ; LoBuglio AF; Stephens RL; Gehan EA; Cummings GD
Cancer; 1984 Mar; 53(5):1029-35. PubMed ID: 6198064
[TBL] [Abstract][Full Text] [Related]
18. Improved survival with cyclic chemotherapy for nonseminomatous germ cell tumors of the testis.
Logothetis CJ; Samuels ML; Selig D; Swanson D; Johnson DE; von Eschenbach AC
J Clin Oncol; 1985 Mar; 3(3):326-35. PubMed ID: 2579213
[TBL] [Abstract][Full Text] [Related]
19. Treatment of retroperitoneal residual tumor after PVB chemotherapy of nonseminomatous testicular tumors.
Gelderman WA; Koops HS; Sleijfer DT; Oosterhuis JW; Oldhoff J
Cancer; 1986 Oct; 58(7):1418-21. PubMed ID: 2427186
[TBL] [Abstract][Full Text] [Related]
20. Transient rise in tumor marker after initial adjuvant chemotherapy for testicular cancer.
Wolf DJ; Williams JJ
Urology; 1982 Jul; 20(1):50-2. PubMed ID: 6180542
[No Abstract] [Full Text] [Related]
[Next] [New Search]
